Understand the source comparison
SS-31 Stacking Guide: Protocol Comparison
SS-31 + NAD+ Precursor (NMN/NR) Cardiolipin stabilization preserves Complex I during NAD+ surge; prevents ROS spike from increased electron flux SS-31 hour 0, NMN 60–90 min later 2.8–3.2× improvement (per Cell Metabolism 2023 study) Aging research, neurodegene
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- SS-31 + NAD+ Precursor (NMN/NR)
- Cardiolipin stabilization preserves Complex I during NAD+ surge; prevents ROS spike from increased electron flux
- SS-31 hour 0, NMN 60–90 min later
- 2.8–3.2× improvement (per Cell Metabolism 2023 study)
- Aging research, neurodegeneration models, exercise performance
- SS-31 + CoQ10 (Ubiquinol)
- Saturated ubiquinol pool operates in stabilized membrane environment; reduces electron leak at Q-cycle
- CoQ10 hour 0, SS-31 hour 5
- 1.9–2.4× improvement
- Cardiovascular research, heart failure models, ischemia-reperfusion
- SS-31 + MOTS-C
- Membrane stabilization prevents ROS during MOTS-C-induced metabolic shift to fatty acid oxidation
- SS-31 + Humanin hour 0, MOTS-C 90–120 min later
- 2.1–2.6× improvement
- Metabolic syndrome research, insulin resistance, sarcopenia
- SS-31 + Humanin + PQQ
- Triple pathway: cardiolipin protection (SS-31), anti-apoptotic signaling (Humanin), mitochondrial biogenesis (PQQ)
- All co-administered hour 0
- 2.5–3.0× improvement
- Neurodegenerative disease, traumatic brain injury, stroke models
- SS-31 + Full Stack (NAD+ + CoQ10 + MOTS-C)
- Maximum pathway convergence; all rate-limiting steps addressed simultaneously
- CoQ10 hour 0, SS-31 hour 5, NMN + MOTS-C hour 6
- 3.5–4.2× improvement (projected from combined mechanisms)
- Comprehensive mitochondrial dysfunction research, multi-system aging models